Detection of genomic mutations in blood and urine free circulating tumour DNA in patients with inoperable and metastatic lung adenocarcinoma harbouring an EGFR mutation in tissue: a UK pilot study

The development of methodologies to analyse circulating tumour DNA (ctDNA) in the blood or urine of cancer patients provides an invaluable resource that can be used for diagnosis and prognosis and to evaluate response to treatments. Lung cancer has seen in the last years a revolution in treatment st...

Descripción completa

Detalles Bibliográficos
Autores principales: Brooks, Helen, Li, Ling, Addeo, Alfredo, Stevens, Megan, Comins, Charles, Oltean, Sebastian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10354425/
https://www.ncbi.nlm.nih.gov/pubmed/37476385
http://dx.doi.org/10.3389/fonc.2023.1197037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10354425/
https://www.ncbi.nlm.nih.gov/pubmed/37476385
http://dx.doi.org/10.3389/fonc.2023.1197037

Ejemplares similares